Allergan Bull Case
Here are some ways that investors could benefit from investing in Allergan plc:
- The current stock price is around $720, reflecting strong market confidence in Allergan plc's growth potential.
- Allergan plc has a diverse portfolio of products across various therapeutic areas, including innovative treatments for neurodegenerative disorders and advanced medical aesthetics, which can drive revenue growth.
- The company is actively developing novel therapies, such as RST-001, a gene therapy for retinitis pigmentosa, positioning itself at the forefront of cutting-edge medical advancements.
- Strategic collaborations with companies like Editas Medicine, Inc. enhance Allergan plc's research capabilities and expand its product pipeline, potentially leading to lucrative market opportunities.
- Allergan plc's established presence in both the US and international markets allows for a broad customer base, reducing dependency on any single market and mitigating risks.